Case Overview: Kroger has agreed to a $17 million class action settlement to resolve allegations that it overcharged insured customers on prescription drug co-payments.

Consumers Affected: Insured customers who paid co-payments for prescription drugs at Kroger pharmacies and may have been overcharged.

Court: To be confirmed upon settlement approval.

Kroger Agrees to $17 Million Settlement Over Alleged Prescription Drug Co-Pay Overcharges

Kroger has agreed to pay $17 million to resolve a class action lawsuit alleging the grocery and pharmacy giant inflated co-payments charged to insured customers on prescription drug purchases, according to recent reporting on the settlement. The proposed settlement, if approved by a court, could provide compensation to a potentially large pool of affected consumers.

Lawsuit Claims Kroger Systematically Overcharged Insured Customers at the Pharmacy Counter

According to the complaint, Kroger allegedly charged insured customers co-payments that exceeded the amounts the pharmacy itself had negotiated with drug suppliers and pharmacy benefit managers (PBMs). The lawsuit alleges the company should have been using lower "usual and customary" drug prices as the basis for calculating co-pays — but instead passed on inflated costs to customers who relied on their insurance at checkout.

The lawsuit claims this practice meant insured patients were routinely paying more out of pocket than they should have, with the overcharges allegedly benefiting Kroger at customers' expense. The plaintiff argues this conduct was not an isolated error but a systemic pricing practice affecting a broad class of consumers.

Who May Be Affected

The settlement class is reported to include insured customers who paid prescription drug co-payments at Kroger pharmacy locations. Kroger operates one of the largest supermarket-based pharmacy networks in the United States, with pharmacy counters in hundreds of store locations across multiple states, meaning the potential class of affected consumers could be substantial.

Customers who filled prescriptions using health insurance — rather than paying the full cash price — and paid co-payments that the lawsuit alleges were improperly inflated would fall within the scope of the claims.

The "Usual and Customary" Pricing Dispute

At the heart of the lawsuit is a legal concept known as "usual and customary" pricing. Under standard pharmacy benefit agreements, pharmacies are generally required to report their usual and customary price to insurers and PBMs — typically understood as the cash price offered to the general public. The lawsuit alleges that Kroger failed to account for discount programs that effectively lowered the true cash price of certain drugs, resulting in co-payment calculations based on artificially higher prices.

This type of allegation has surfaced in litigation involving other major pharmacy chains in recent years, with plaintiffs arguing that the failure to accurately report usual and customary prices harms insured consumers who are often unaware of the discrepancy at the point of sale.

$17 Million Settlement Reached

Kroger has agreed to a $17 million settlement fund to resolve the claims without admitting wrongdoing. If the court grants final approval, class members may be eligible to receive a portion of the settlement fund, though individual payment amounts would depend on factors such as the number of valid claims submitted and the scope of each claimant's alleged overpayments.

Consumers who believe they may fall within the class definition could potentially submit a claim to receive compensation, pending court approval of the settlement terms and any claims administration process that follows.

Broader Pattern of Pharmacy Co-Pay Litigation

Kroger is not the first major pharmacy operator to face this type of allegation. Similar lawsuits have been filed against other national pharmacy chains over the past several years, with plaintiffs arguing that pharmacy benefit structures create opportunities for overcharging insured consumers who have little visibility into what they should actually be paying.

Regulatory scrutiny of pharmacy pricing practices, particularly around the role of PBMs in setting drug costs, has also intensified at both the federal and state levels in recent years, lending broader context to the consumer concerns underlying cases like this one.

Lawsuit: [Plaintiff] v. The Kroger Co.

Case Number: To be confirmed

Court: To be confirmed

Settlement Amount: $17,000,000 (proposed; pending court approval)

Plaintiffs' Attorney(s): To be confirmed

This article is for informational purposes only and does not constitute legal or medical advice. Eligibility for any settlement payment can only be determined through the official claims process or by consulting a qualified attorney.

Have you paid prescription drug co-payments at a Kroger pharmacy? Share your experience in the comments below.